Home › Products › Oncology › Tukavo 50mg Tablet
Tukavo 50mg Tablet
Salt Composition: TUCATINIB
- Manufacturer: ZYDUS CADILA
- Pack Size: 60 TABLET(s) IN A BOTTLE
- Dosage Form: TABLET
- Strength: 50MG
- Prescription Required
- Storage: Store below 30°C in a dry place, away from direct sunlight. Keep in the original blister or bottle until ready to use. Do not freeze or expose to moisture. Keep out of reach of children and pets. Safely discard expired or unused capsules—do not flush them.
₹17340.00₹21145.31
Inclusive of all taxes
Product Introduction
Tukavo 50mg Tablet is indicated for the treatment of HER2-positive breast cancer, particularly when metastatic disease including brain involvement is present. It is administered in combination with trastuzumab and capecitabine. Tucatinib, the active ingredient in Tukavo 50mg Tablet, functions by inhibiting HER2 protein, which promotes cancer cell proliferation. This mechanism helps arrest or reduce further cancer progression. Tucatinib is not a chemotherapy agent but a targeted therapy that acts selectively on cancer cells whilst minimising effects on healthy tissue. Administration requires medical supervision with periodic monitoring during treatment to ensure therapeutic efficacy and safety.
Uses
Tukavo 50mg Tablet is used for: HER2-positive advanced or metastatic breast cancer Brain metastases in HER2+ breast cancer patients Use in combination with trastuzumab and capecitabine after previous HER2-directed therapies This therapy is typically considered when other standard HER2 treatments have become ineffective.
How it works
Tukavo 50mg Tablet belongs to a group of medicines known as tyrosine kinase inhibitors (TKIs). It works by: Specifically targeting the HER2 receptor, a protein that promotes cancer cell growth Blocking HER2-related signaling pathways that drive tumor progression Working synergistically with other anticancer drugs like trastuzumab and capecitabine Crossing the blood-brain barrier to treat cancer that has spread to the brain This focused mechanism helps slow disease progression while minimizing impact on normal cells.
Side Effects
Common Side Effects Some people may have: Loose motion (diarrhea) Feeling very tired Nausea or vomiting Mouth sores Less hunger Red or sore hands and feet Liver test changes (seen in blood reports) These usually go away with time or treatment. Tell your doctor if any feel too strong or last long. Serious Side Effects (Call Your Doctor Right Away) Yellow skin or eyes (could mean a liver problem) Bad diarrhea with weakness Trouble breathing or swelling (could be an allergy) High fever or infections Report any unexpected or persistent side effects to your doctor immediately.
Expert Tips
Keep oral rehydration salts (ORS) handy in case of diarrhea. Use sunscreen and moisturizers to prevent skin reactions on hands and feet. Stick to a mild diet if experiencing nausea; avoid spicy or greasy foods. Inform your healthcare provider if you’re taking any over-the-counter meds. Track side effects daily using a treatment journal—it helps your doctor manage symptoms early.
References
- https://www.ncbi.nlm.nih.gov/books/NBK595112/
- https://www.nejm.org/doi/full/10.1056/NEJMoa1914609
- https://pubchem.ncbi.nlm.nih.gov/compound/Tucatinib
Safety Advice
Pregnancy: Unsafe Use of this medicine is not recommended during pregnancy. Women of childbearing potential should use effective contraception during treatment and for at least 1 week after the last dose to avoid potential harm to the unborn baby.
Lungs: Consult Your Doctor Tukavo 50mg Tablet should be used with caution in lung cancer patients, and only under the supervision of an oncologist, as it may cause serious side effects like liver toxicity and diarrhea.
Breastfeeding: Consult Your Doctor Breastfeeding is not advised while taking this medicine, as it may pass into breast milk and could harm the baby. Talk to your doctor about safer alternatives or when it's safe to resume breastfeeding.
Disclaimer
The information provided on this page is intended for general informational purposes only and should not be considered as medical advice. Always consult a qualified healthcare professional before starting, stopping, or changing any medication. Self-medication can be harmful. Med For Rare does not endorse self-diagnosis or self-treatment.